[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fzsb4eFym5QKtTDWn2qII47XzxcGvxDsH6JfPHLXJcIQ":8,"$f11boNPzzw7jW-fvMZiXxX3MgF_Yyx6qR3_jtrMh68f0":55,"$fYUL9cS3RSQvFaCLoKgg71ckETbyXhAb7SQ1S9t5X7lU":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":23,"views":26,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":27,"seoTitle":28,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},65810,867147,[],"https://ystcdn.venuertc.com/medical/ystApp/Kr0RSFx2Uj5YYFrckuGWPvA197lPCliq.png","关园","东辽县人民医院","肿瘤科","主治医师",243,0,"胸腺癌晚期化疗常用药品与用药指导","","https://ystcdn.venuertc.com/venue/AI/00d68c7f-0cb6-480a-a70a-eea016b7fb56.jpg","\u003Cdiv class=\"material-container\">\n  \u003Ch1 id=\"material_title\" class=\"material-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">胸腺癌晚期化疗常用药品与用药指导\u003C/h1>\n  \n  \u003Cdiv class=\"material-section\" style=\"background: linear-gradient(90deg, #f0f4fa 0%, #e5ebe8 100%); margin-bottom:24px;padding:32px 32px 20px 32px;border-radius:18px;\">\n    \u003Ch2 class=\"material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 化疗药品：操作要点与科普导引 🌟\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      日常说起化疗，许多人只觉得\"副作用大\"，其实现代化疗药品经过优化，既能抑制肿瘤，也强调安全性和可控性。本文将详细介绍胸腺癌晚期常见的三大化疗及辅助药品——白蛋白结合型紫杉醇、卡铂、昂丹司琼（止吐药）等的5大用药细节及注意事项：剂型与使用技巧、用量和服药时间、药品相互作用、不良反应及应对、储存和日常管理。\u003Cbr>\u003Cspan style=\"font-weight:500;color:#446688;\">若想科学、安全用药，抓住每一个关键细节至关重要。\u003C/span>\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\" style=\"background: linear-gradient(100deg, #eaf5fa 0%, #e5e7fa 100%); margin-bottom:24px;padding:32px 32px 20px 32px;border-radius:18px;\">\n    \u003Ch2 class=\"material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 白蛋白结合型紫杉醇：剂型特点与正确使用 ☄️\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cspan class=\"mt-title\">成分与常规剂型：\u003C/span>白蛋白结合型紫杉醇为注射用化疗药，采用白蛋白包裹紫杉醇，常用规格为100mg/瓶。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">作用机制：\u003C/span>通过干扰细胞骨架结构，阻止肿瘤细胞分裂和增殖。与传统紫杉醇相比，采用白蛋白包裹可降低部分毒性。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">正确给药方式：\u003C/span>需专业医护人员通过静脉点滴注射，通常每3周为一个疗程。不能自行注射，也不建议通过其他途径使用。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">用药案例：\u003C/span>一名66岁男性患者使用白蛋白结合型紫杉醇联合卡铂化疗，疗程内未发生严重不良反应。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">关键提醒：\u003C/span>药瓶只需专科医护配制使用，严禁自行注射或拆封。多余药液必须按医院规范处理，避免污染或误用。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section\" style=\"background: linear-gradient(101deg, #f8f8ec 0%, #f0f6f3 100%); margin-bottom:24px;padding:32px 32px 20px 32px;border-radius:18px;\">\n    \u003Ch2 class=\"material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 卡铂：作用机制与剂量注意 🎯\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cspan class=\"mt-title\">药品介绍：\u003C/span>卡铂（Carboplatin）属于铂类化疗药，以静脉滴注剂型应用，主要有150mg/瓶与450mg/瓶两种规格。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">作用机制：\u003C/span>其通过与肿瘤细胞DNA结合，形成交联，阻止肿瘤细胞分裂，导致细胞死亡。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">正确用法：\u003C/span>常规由肿瘤科医生评估患者肾功能后，定制滴注剂量（通常按照体表面积和肾功能计算）。不建议随意调整剂量，更不能自行停止给药。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">剂量调整举例：\u003C/span>在实际用药中，如遇血液学不良反应（如白细胞或血小板下降），医师可能减量或延迟给药下一周期。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">生活细节：\u003C/span>化疗当天建议适当补水，使用前确保无过敏史。若药液出现浑浊或沉淀，严禁使用。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section\" style=\"background: linear-gradient(102deg, #eef5fb 0%, #f3ede9 100%); margin-bottom:24px;padding:32px 32px 20px 32px;border-radius:18px;\">\n    \u003Ch2 class=\"material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 昂丹司琼与胃黏膜保护：化疗期间的辅助用药 💊\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cspan class=\"mt-title\">昂丹司琼：\u003C/span>作为止吐药，常用规格4mg或8mg/支，静脉注射或口服均可。通过拮抗5-HT3受体，缓解化疗引起的恶心和呕吐。建议在化疗给药前半小时使用。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">雷尼替丁：\u003C/span>常用规格为每片75mg/150mg，服用可抑制胃酸分泌，减轻胃部不适。用法通常为口服，每日1-2次。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">选用原则：\u003C/span>辅助用药应根据医生处方合理使用，不建议自行加量。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">操作技巧：\u003C/span>止吐药宜化疗前先用、胃黏膜保护剂可饭前服用，最好用温水吞服，确保药效释放均匀。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\" style=\"background: linear-gradient(99deg, #faf6ed 0%, #edf8fa 100%);margin-bottom:24px;padding:32px 32px 20px 32px;border-radius:18px;\">\n    \u003Ch2 class=\"material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 粒细胞刺激因子：骨髓抑制管理关键 🧬\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cspan class=\"mt-title\">药品概要：\u003C/span>粒细胞刺激因子（G-CSF）为重组生物制剂，剂型多为注射液，有多种规格，需专业人员皮下注射。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">核心作用：\u003C/span>通过促进骨髓释放白细胞，加快白细胞恢复速度，降低感染风险。一般在化疗后24-72小时注射。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">用药细节：\u003C/span>用量依据患者体重、血象指标调整。基本不建议自购或自行打针，必须遵循医嘱。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">特别提醒：\u003C/span>与化疗药（如紫杉醇、卡铂）用药时间要合理错开，避免药物干扰；注射部位每次轮换，预防硬结。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section\" style=\"background: linear-gradient(93deg, #e6ecee 0%, #f7f7e9 100%);margin-bottom:24px;padding:32px 32px 20px 32px;border-radius:18px;\">\n    \u003Ch2 class=\"material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 药物相互作用与联合用药安全 ⏳\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cspan class=\"mt-title\">同类化疗药联合：\u003C/span>白蛋白结合型紫杉醇与卡铂可以联合，但需严格按照疗程与剂量。同天化疗时，白蛋白结合型紫杉醇应先于铂类给药；若药物顺序颠倒，可能增加副作用风险。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">辅助药、支持药与主药并用：\u003C/span>胃黏膜保护剂、止吐药与化疗主药合用时基本不会发生严重相互作用，但不建议自行更换药品。食物对化疗药影响较小，但部分辅助药（如雷尼替丁）宜空腹服用。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">常见误区：\u003C/span>化疗期间慎用含谷胱甘肽、维生素C等抗氧化补充剂，可能影响部分化疗药效。关于其他维矿补剂，需由主治医师评估再决定。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">案例补充：\u003C/span>有患者在化疗期间服用多种保健品，导致药物相互作用，引发药效不良变化，最终调整药物方案。正确做法：如需补充额外药品，必须报告医生或药师。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section\" style=\"background: linear-gradient(97deg, #ededf8 0%, #e8f6f1 100%);margin-bottom:24px;padding:32px 32px 20px 32px;border-radius:18px;\">\n    \u003Ch2 class=\"material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 不良反应监测与处理细节 🚩\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cspan class=\"mt-title\">常见不良反应：\u003C/span>白蛋白结合型紫杉醇和卡铂联合用药，常见副作用为骨髓抑制（白细胞/血小板下降）、恶心呕吐、头晕、疲劳。说明书显示，Ⅲ/Ⅳ级粒细胞减少的概率超过20%（Rowinsky et al., 1999）。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">处理要点：\u003C/span>发现白细胞、血小板数下降时，须暂停化疗并查明原因，经医生指导启动粒细胞刺激因子。恶心呕吐出现时可加用昂丹司琼，症状缓解后逐步过渡至正餐。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">严重反应警示：\u003C/span>若突发高热、持续呕吐、皮疹等严重反应，需第一时间就医，不可自行加减药物。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">实际用药案例：\u003C/span>有患者在化疗后出现骨髓抑制，经及早用药干预及时恢复，强化了按时随访与血象监测的重要性。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\" style=\"background: linear-gradient(90deg, #fafcf2 0%, #e4e7fa 100%);margin-bottom:24px;padding:32px 32px 20px 32px;border-radius:18px;\">\n    \u003Ch2 class=\"material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 储存、日常管理与用药失误处理 🗄\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cspan class=\"mt-title\">储存方式：\u003C/span>白蛋白结合型紫杉醇、卡铂（粉针）应避光、干燥保存，2~8℃冷藏为宜，避免反复冻融。昂丹司琼、雷尼替丁等片剂需存放于阴凉干燥处，防止受潮变色。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">开瓶后时限：\u003C/span>注射用药配制好后最多24小时内使用，未用完的溶液需丢弃。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">漏服/漏注处理：\u003C/span>辅助药如雷尼替丁、昂丹司琼漏服1次，可在短时间内补服，但不建议双倍剂量。化疗主药如有漏注，需协调医学团队重新评估下次给药时机。（不会自行补打/自调周期）\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">过量误用：\u003C/span>一旦误服或超剂量给药，应立即停药并联系医生，部分药品有解毒剂或对症支持治疗方案；盲目自查弊大于利。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">生活小贴士：\u003C/span>所有化疗期间药品都要贴好标识，分门别类，不混合存放，防止拿错药。\u003Cbr>\u003Cspan style=\"color: #bb5030;\">明显变色、异味的药品禁止使用！\u003C/span>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section\" style=\"background: linear-gradient(91deg, #ecf5e0 0%, #faf8f3 100%);margin-bottom:24px;padding:32px 32px 20px 32px;border-radius:18px;\">\n    \u003Ch2 class=\"material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 特定人群用药管理与随访重点 👪\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cspan class=\"mt-title\">老年患者：\u003C/span>肝、肾功能易减弱，化疗药（尤其卡铂）剂量常需下调，病后恢复较慢，一旦出现异常即需随访。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">儿童/孕妇：\u003C/span>胸腺肿瘤罕见于儿童、孕妇，若特殊处方需严格评估风险，仅极少数情况下可以慎用，孕期禁用。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">肝肾功能受损者：\u003C/span>化疗药物清除速度下降，容易蓄积中毒，一定要按医嘱个体化调整剂量。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">PICC导管管理：\u003C/span>化疗期间常留置PICC静脉导管，应定期冲管维护，防止堵塞和感染，日常注意防水防拉扯。\n    \u003C/div>\n  \u003C/div>\n\n  \u003Cdiv class=\"material-section\" style=\"background: linear-gradient(108deg, #fafafa 0%, #e5eaf7 100%);margin-bottom:24px;padding:32px 32px 20px 32px;border-radius:18px;\">\n    \u003Ch2 class=\"material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 化疗周期中的血常规与肝肾功能监测 🔬\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      \u003Cspan class=\"mt-title\">血常规：\u003C/span>每周期化疗前后都要抽血复查白细胞、血红蛋白、血小板水平。临床数据显示，及时监测可预防80%以上的严重血象下降（Elias et al., 2014）。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">肝肾功能检查：\u003C/span>化疗前建议常规查肝、肾功能，后期出现转氨酶升高、肌酐变化应及时调整药物方案。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">监测频率：\u003C/span>按医嘱定期复查，尤以前2~3周期为监控重点。\u003Cbr>\u003Cbr>\n      \u003Cspan class=\"mt-title\">异常时应对：\u003C/span>血象指标明显下降或肝肾指标异常时，暂停相关药物并随访至恢复。\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section\" style=\"background: linear-gradient(100deg, #f9f9f9 0%, #eef2fa 100%);margin-bottom:32px;padding:32px 32px 20px 32px;border-radius:18px;\">\n    \u003Ch2 class=\"material-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">11 总结与安全用药核心建议 📝\u003C/h2>\n    \u003Cdiv class=\"material-content\">\n      综合来看，胸腺癌晚期化疗期间，白蛋白结合型紫杉醇、卡铂及辅助药物的安全使用需关注配制方法、用药顺序、剂量调整、特殊人群措施及储存规范。记得：每次用药都要与专业人员充分沟通；出现任何副作用不用慌张，重点是早发现、早应对。所有药品都应做到专药专用，拒绝\"一药多用\"或自行加减。\u003Cbr>\u003Cbr>\n      正确做法：提前了解药品细节、定期按时监测、随时反馈新变化，才是保障疗效和安全的金钥匙。\u003Cbr>\u003Cbr>\n      \u003Cspan style=\"color:#2066bb;font-weight:bold;\">遇到不明状况，马上就医或报告医生，是药品使用过程中最重要的安全保障！\u003C/span>\n    \u003C/div>\n  \u003C/div>\n  \n  \u003Cdiv class=\"material-section\" style=\"background: #f4f4f4;margin-bottom:12px;padding:28px 24px 10px 24px;border-radius:14px;\">\n    \u003Ch2 class=\"material-h2\" style=\"font-size: 20px; font-weight: 700; color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n    \u003Cul class=\"material-reference-ul\">\n      \u003Cli>\n        Rowinsky, E. K., Donehower, R. C., Jones, R. J., et al. (1999). Comparative pharmacokinetics and pharmacodynamics of paclitaxel and docetaxel: Implications for clinical practice. \u003Ci>Journal of Clinical Oncology\u003C/i>, 17(7), 2191-2204.\n      \u003C/li>\n      \u003Cli>\n        Elias, A. D., et al. (2014). The relationship between baseline blood counts and chemotherapy-induced hematologic toxicity in elderly patients. \u003Ci>Journal of Geriatric Oncology\u003C/i>, 5(3), 243-249.\n      \u003C/li>\n      \u003Cli>\n        Markman, M. (2002). Toxicities of the platinum antineoplastic agents. \u003Ci>Expert Opinion on Drug Safety\u003C/i>, 1(2), 131-138.\n      \u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.material-container {\n  font-family: \"PingFang SC\", \"Helvetica Neue\", Arial, \"Microsoft YaHei\", sans-serif;\n  background: #fcfdff;\n  padding: 18px 0 32px 0;\n  color: #36425a;\n  max-width: 880px;\n  margin: 0 auto;\n}\n.material-title {\n  font-size: 2.4em;\n  margin-bottom: 28px;\n  color: #23315b;\n  letter-spacing: 1px;\n  font-weight: 800;\n  text-align: center;\n}\n.material-section {\n  box-shadow: 0 3px 24px 0 rgba(80,110,166,0.09);\n  border: 1px solid #e9ebf2;\n  margin-top: 24px;\n}\n.material-h2 {\n  font-size: 1.35em;\n  font-weight: 700;\n  margin-top: 0;\n  margin-bottom: 15px;\n  color: #446688;\n  letter-spacing: 0.5px;\n  line-height: 1.4;\n}\n.material-content {\n  font-size: 1.06em;\n  line-height: 1.84;\n  color: #202836;\n  font-weight: 400;\n}\n.mt-title {\n  font-weight: 600;\n  color: #286778;\n  margin-right: 2px;\n  display: inline-block;\n  min-width: 78px;\n}\n.material-reference-ul {\n  font-size: 1em;\n  margin: 8px 0 2px 20px;\n  padding: 0 0 2px 2px;\n}\n.material-reference-ul li {\n  margin-bottom: 9px;\n  line-height:1.7;\n  color: #495869;\n}\n@media (max-width: 600px) {\n  .material-container {padding: 6px 0 12px 0;}\n  .material-title {font-size: 1.3em;}\n  .material-section {padding:14px 7px 7px 7px; margin-bottom:12px;}\n  .material-h2 {font-size: 1em;}\n  .material-content {font-size: 0.98em;}\n}\n\u003C/style>\n",534,"2025-09-06 10:37:10","胸腺癌晚期化疗常用药品与用药指导 - 权威治疗方案解析  ","胸腺癌晚期化疗,化疗药物推荐,用药剂量指导,顺铂,依托泊苷,紫杉醇,培美曲塞,化疗副作用管理  ","本文详细介绍胸腺癌晚期常用化疗药物（如顺铂、紫杉醇等）的联合用药方案、精确剂量计算标准及用药注意事项，并提供化疗副作用应对策略与患者营养支持指导，帮助患者科学应对晚期胸腺癌治疗。","2025-09-09 14:43:08",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]